Article

HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Karolinska University Hospital Huddinge, S-141 86 Stockholm, Sweden.
Blood (Impact Factor: 10.43). 12/2004; 104(9):2810-7. DOI: 10.1182/blood-2003-07-2314
Source: PubMed

ABSTRACT Dendritic cells (DCs) are antigen-presenting cells with the capacity to prime naive T cells for efficient cellular responses against pathogens such as HIV-1. DCs are also susceptible to HIV-1 infection, which may impair their ability to induce immunity. Here, we examined the ability of HIV-1-infected, in vitro-derived DCs to respond to CD40 ligand (CD40L) stimulation with the aim to study events during early HIV-1 infection. HIV-1(BaL)-infected p24(+) DCs were detected after only 3 days of exposure to highly concentrated virus. We show that HIV-1-infected DCs up-regulated costimulatory molecules, but were skewed in their production of effector cytokines in response to CD40L stimulation. CD40L stimulation induced significant secretion of tumor necrosis factor alpha (TNFalpha) and interleukin 12 (IL-12) p70 from both HIV-1-exposed and unexposed DCs. Intracellular stainings of HIV-1-exposed DCs revealed that TNFalpha could be detected in both the p24(-) and p24(+) DCs, but IL-12 p70 could be found only in the p24(-) DCs. Thus, although p24(+) DCs showed a mature phenotype similar to p24(-) DCs after CD40L stimulation, they appeared to have an impaired cytokine profile. These observations suggest that HIV-1 infection disables DC function, a phenomenon that may be relevant for optimal induction of HIV-1-specific immune responses.

Download full-text

Full-text

Available from: Jan Andersson, May 06, 2014
0 Followers
 · 
75 Views
  • Source
    • "Viral infection Impaired maturation/function (Virus-dependent) Downregulation of CD1a, CD1b, DC-SIGN, CD80, CD83, CD86 IFNα, IL-10, IL-1β (missing IL-12, IL-6, TNFα secretion) Kruse et al., 2000; Sarobe et al., 2003; Smed-Sorensen et al., 2004; Martinson et al., 2007; Tilton et al., 2008; Harman et al., 2011; Chentoufi et al., 2012; Dental et al., 2012; Tu et al., 2012 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The immune system exists in a delicate equilibrium between inflammatory responses and tolerance. This unique feature allows the immune system to recognize and respond to potential threats in a controlled but normally limited fashion thereby preventing a destructive overreaction against healthy tissues. While the adaptive immune system was the major research focus concerning activation versus tolerance in the immune system more recent findings suggest that cells of the innate immune system are important players in the decision between effective immunity and induction of tolerance or immune inhibition. Among immune cells of the innate immune system dendritic cells (DCs) have a special function linking innate immune functions with the induction of adaptive immunity. DCs are the primary professional antigen presenting cells (APCs) initiating adaptive immune responses. They belong to the hematopoietic system and arise from CD34+ stem cells in the bone marrow. Particularly in the murine system two major subgroups of DCs, namely myeloid (mDCs) and plasmacytoid DCs (pDCs) can be distinguished. DCs are important mediators of innate and adaptive immunity mostly due to their remarkable capacity to present processed antigens via major histocompatibility complexes (MHC) to T cells and B cells in secondary lymphoid organs. A large body of literature has been accumulated during the last two decades describing which role DCs play during activation of T cell responses but also during the establishment and maintenance of central tolerance (Steinman et al., 2003). While the concept of peripheral tolerance has been clearly established during the last years, the role of different sets of DCs and their particular molecular mechanisms of immune deviation has not yet fully been appreciated. In this review we summarize accumulating evidence about the role of regulatory dendritic cells in situations where the balance between tolerance and immunogenicity has been altered leading to pathologic
    Frontiers in Immunology 09/2012; 3:274. DOI:10.3389/fimmu.2012.00274
  • Source
    • "Lin et al. tested vesicular stomatitis virus glycoprotein-pseudotyped replication-defective simian immunodeficiency viruses (dSIVs) as an anti-HIV vaccine and found that CD40L- dSIVs enhanced activation of rhesus macaque DCs, enhanced proliferation and IFN-secretion by naïve T cells and induced stronger humoral and cell mediated immunity in mice [169]. Importantly, the defective IL-12 production by PBMC from HIV-infected patients can be restored upon stimulation with IFN-and CD40L [139] [144] [170]. DCs engineered with CD40L are very potent for priming naïve anti-HIV CD8 + T-cell responses and enhancing pre-existing HIV-specific CD8 + T-cell responses [128] [171]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: HIV infection is characterized by a number of abnormalities in several components of the immune system. For example, during HIV infection, a massive decrease of CD4(+) T cells is observed, as well as a progressive depletion of naïve CD8(+) T cells. Furthermore, elevated numbers of apoptotic B and T cells are present in HIV-infected patients, and a systemic immune activation results in T-cell exhaustion. Finally, HIV infection is characterized by the presence of functionally impaired dendritic cells, with decreased expression of maturation markers, decreased secretion of cytokines and defects in antigen processing and presentation. All these characteristics result in the occurrence of non-functional cytotoxic T lymphocytes, that fail to control HIV-replication in most individuals during progressive disease. Costimulatory and co-inhibitory molecules are involved in the activation, differentiation and survival of several cell-types of the immune system. Each costimulatory receptor (generally expressed on effector cells) can conjugate with one or more specific ligands (expressed on antigen-presenting cells), which leads to an activation of intracellular signaling pathways inside the cells on which they are expressed. HIV infection is characterized by an aberrant expression of these molecules on cells of the immune system. Many of the immune deficiencies mentioned in the previous paragraph can be explained by abnormal expression of costimulatory molecules, and could consequently be overcome by interfering with their interactions. In this review, we give an overview of the functions and expression patterns of the receptor/ligand pairs of the tumor necrosis factor and the B7 super-families of costimulatory and co-inhibitory molecules in HIV-infected patients. We will also discuss possibilities for manipulating their signaling as a therapeutic anti-HIV tool.
    Current Molecular Medicine 03/2011; 11(3):172-96. DOI:10.2174/1566211213754945240 · 3.61 Impact Factor
  • Source
    • "The modulation of DCs by HIV infection is a key aspect in viral pathogenesis. It contributes to viral evasion from immunity because the dysfunction of DC engenders some impairment effects for CTL inducement [11] [26] [34] [35]. Furthermore, progressive loss of the DC number and function during the course of HIV-1 infection are reported in [10] [11] [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Results of several studies show that some DC populations are susceptible to HIV. Modulation of DCs by HIV infection, in particular interference of the antigen-presenting function of DCs, is a key aspect in viral pathogenesis and contributes to viral evasion from immunity because the loss of the DC function engenders some impairment effects for a proliferation of CTL responses, which play an important role in the immune response to HIV. As described herein, we use a simple mathematical model to examine virus-immune dynamics over the course of HIV infection in the context of the immune impairment effects. A decrease of the DC number and function during the course of HIV-1 infection is observed. Therefore, we simply assumed that the immune impairment rate increases over the HIV infection. Under the assumption, four processes of the disease progression dynamics of our model are classifiable according to their virological properties. It is particularly interesting a typical disease progression presents a "risky threshold" and an "immunodeficiency threshold". Regarding the former, the immune system might collapse when the impairment rate of HIV exceeds a threshold value (which corresponds to a transcritical bifurcation point). For the latter, the immune system always collapses when the impairment rate exceeds the value (which corresponds to a saddle-node bifurcation point). To test our theoretical framework, we investigate the existence and distribution of these thresholds in 10 patients.
    Journal of Theoretical Biology 08/2009; 260(4):490-501. DOI:10.1016/j.jtbi.2009.06.023 · 2.30 Impact Factor
Show more